Jordi Guardiola

A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease

William J. Sandborn, Subrata Ghosh, Julián Panés et al. · Clinical Gastroenterology and Hepatology · 2014 · 295 citations

Inflammation, Chronic Inflammatory Diseases, Anti-inflammatory +9

Spontaneous bacterial empyema in cirrhotic patients: A prospective study

Xavier Xiol, Josep M. Simón Castellví, Jordi Guardiola et al. · Hepatology · 1996 · 226 citations

Pneumothorax, Gastroenterology, Pathology +11

A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization

Laura Llad�, Joan Virgili, Joan Figueras et al. · Cancer · 2000 · 169 citations

A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease

Triana Lobatón, Alicia López‐García, Francisco Rodríguez‐Moranta et al. · Journal of Crohn s and Colitis · 2013 · 154 citations · Full text

Fecal Level of Calprotectin Identifies Histologic Inflammation in Patients With Ulcerative Colitis in Clinical and Endoscopic Remission

Jordi Guardiola, Triana Lobatón, Lorena Rodríguez‐Alonso et al. · Clinical Gastroenterology and Hepatology · 2014 · 129 citations

Inflammation, Mucosal Immunology, Immunology +8